Glomeria Therapeutics

Italy
Galleno, Tuscany, Italy, 66100

Company profile

Glomeria Therapeutics company profile

Glomeria Therapeutics researches, develops, and markets new medical devices for the treatment of serious diseases in the nephrological area. It offers DesmoPD, peritoneal dialysis connection system; SmartPD, an automated management device for peritoneal dialysis solutions to be instilled in peritoneum; and solutions for peritoneal dialysis. Andrea Zanella founded Glomeria Therapeutics in 2010. Its headquarters is in Chieti in Italy.

Business identity

Contact email
[email protected]
Phone number
+390871562276
Operating status
Closed
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2010-01-01, Year

Headquarters

Postal code
66100
Country code
IT
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
3
Total equity funding
$1.1M
Last funding
Grant / $3.2M / 2016-10-01
Last equity funding
Series Unknown / $1.1M
Investors
5
Lead investors
1
Founders
1
Articles
1

Founders and investors

Founders

Andrea Zanella

Lead investors

Vertis

Investors

EISMEAGreen Arrow CapitalSofimac Investment ManagersSpindial GroupVertis